Skip to main content

Table 3 Show the prevalence and severity of depression, anxiety and hopelessness in the case and control group

From: Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population

 

Case

Control

p-value

Severity of depression

 Minimal

53 (53.0%)

60 (60%)

0.157

 Mild

19 (19.0%)

25 (25%)

 Moderate

16 (16.0%)

9 (9%)

 Severe

12 (12.0%)

6 (6%)

Severity of anxiety

 Minimal

32 (32. 7%)

49 (49.5%)

0.015

 Mild

27 (27.6%)

30 (30.3%)

 Moderate

25 (25.5%)

15 (15.2%)

 Severe

14 (14.3%)

5 (5.1%)

Severity of hopelessness

 Minimal

40 (40.0%)

48 (48.5%)

0.006

 Mild

34 (34%)

42 (42.4%)

 Moderate

18 (18.0%)

9 (9.1%)

 Severe

8 (8.0%)

0 (0%)